SCIENTIFIC BACKGROUND

HTT

Huntington disease is an autosomal dominant inherited neurodegenerative disease with a prevalence of 5-7:100,000 in the Central European population. The average age disease onset is 40 years; children and the elderly patients are rarely affected. The symptoms are mainly movement disorders that become choreatic over time, character changes that range from frequent depressive moods and mental deterioration in the beginning to dementia due to atrophy of the caudate nucleus and the putamen or cortex. The disease has an average duration of 15 years.

 

The disease is caused by a CAG triplet repeat expansion in exon 1 of the HTT gene. Normal subjects have alleles with 6-26 CAG repeats; Huntington disease always occurs from 40 repeats onward. There is a certain statistic correlation between repeat length and the age of onset. Due to the CAG repeat expansion, increased glutamine residues are incorporated into the huntingtin protein. This leads to an aggregation of the proteins and thus to a disturbance of the physiological processes in the nerve cells. The mechanism by which atrophy only occurs in certain areas of the brain is not yet fully understood. There is no causal treatment available; movement disorders and psychological changes can be treated symptomatically.

 

In patients who already show symptoms, the symptomatic genetic diagnosis serves to ensure the clinical suspected diagnosis or the differential diagnosis.

 

Predictive diagnostics involves the examination of healthy individuals considered at risk, usually first degree relatives of those affected. According to the German Genetic Diagnostics Act (GenDG), genetic counselling should be offered with every diagnostic genetic examination. According to the GenDG, predictive genetic diagnostics require genetic counselling before the examination and after the results are available (§10, paragraph 2 GenDG). According to the recommendations of professional associations, psychotherapeutic care should be available before, during and after the examination phase.

 

References

Ghosh et al. 2018, Adv Exp Med Biol 1049:1 / McColgan et al. 2017, Eur J Neurol 25:24 / Nance 2017, Am J Med Genet B Neuropsychiatr Genet 174:75 / van der Burg et al. 2009, Lancet Neurol 8:765 / Walker 2007, Lancet 369:218 / McNeil et al. 1997, Hum Mol Genet 6:775 / Rubinsztein et al. 1996, Am J Hum Genet 59:16 / Gellera et al. 1996, Am J Hum Genet 59:475 / Huntington’s Disease Collaborative Research Group 1993, Cell 72:971

GENES

HTT

ASSOCIATED TESTS

How to order

LATEST ARTICLES

Exciting news in genetic research! The Human Pangenome Reference Consortium has unveiled an improved version of the human pangenome reference. This c...

Read more

Duchenne muscular dystrophy, a rare inherited muscle disorder characterized by progressive muscle weakness and degeneration that leads to difficultie...

Read more

May 12 is International Nurses Day. It is celebrated on Florence Nightingale’s birthday. She pioneered the field of modern nursing through her dedi...

Read more

Hair loss is a common problem that affects millions of men and women around the world. While genetics is believed to be the most significant factor c...

Read more

Depression is a serious mental health issue affecting over 280 million people worldwide. Recent research has revealed a potential link between gut he...

Read more

If you are unlucky enough to suffer from migraines, you will know that a migraine is not just a bad headache. The headache and accompanying symptoms ...

Read more

Autism spectrum disorder (ASD) is a neurological developmental disorder that affects brain development and function. This affects how people learn, b...

Read more

Researchers have developed a method called "Mendelian Phenotype Search Engine" (MPSE) to identify which sick infants in the neonatal intensive care u...

Read more

Did you know that wisdom teeth are actually an evolutionary leftover from our ancient ancestors that no longer serve their original purpose? These mo...

Read more

Azoospermia is a medical condition characterized by the absence of sperm in the ejaculate and is a major cause of male infertility. It affects 1 in 1...

Read more